These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18760148)

  • 1. Levodopa improves procedural motor learning in chronic stroke patients.
    Rösser N; Heuschmann P; Wersching H; Breitenstein C; Knecht S; Flöel A
    Arch Phys Med Rehabil; 2008 Sep; 89(9):1633-41. PubMed ID: 18760148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic effects on encoding of a motor memory in chronic stroke.
    Floel A; Hummel F; Breitenstein C; Knecht S; Cohen LG
    Neurology; 2005 Aug; 65(3):472-4. PubMed ID: 16087920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study.
    Restemeyer C; Weiller C; Liepert J
    Restor Neurol Neurosci; 2007; 25(2):143-50. PubMed ID: 17726273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
    Ford GA; Bhakta BB; Cozens A; Hartley S; Holloway I; Meads D; Pearn J; Ruddock S; Sackley CM; Saloniki EC; Santorelli G; Walker MF; Farrin AJ
    Lancet Neurol; 2019 Jun; 18(6):530-538. PubMed ID: 31122493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term levodopa administration in chronic stroke patients. A clinical and neurophysiologic single-blind placebo-controlled cross-over pilot study.
    Acler M; Fiaschi A; Manganotti P
    Restor Neurol Neurosci; 2009; 27(4):277-83. PubMed ID: 19738321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial.
    Ondo WG; Shinawi L; Moore S
    Mov Disord; 2010 Dec; 25(16):2724-7. PubMed ID: 20925074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study.
    Scheidtmann K; Fries W; Müller F; Koenig E
    Lancet; 2001 Sep; 358(9284):787-90. PubMed ID: 11564483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.
    Hauser RA; Hsu A; Kell S; Espay AJ; Sethi K; Stacy M; Ondo W; O'Connell M; Gupta S;
    Lancet Neurol; 2013 Apr; 12(4):346-56. PubMed ID: 23485610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa improves skilled hand functions in the elderly.
    Floel A; Vomhof P; Lorenzen A; Roesser N; Breitenstein C; Knecht S
    Eur J Neurosci; 2008 Mar; 27(5):1301-7. PubMed ID: 18312589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
    Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of improvement in odor identification by levodopa in humans.
    Rösser N; Berger K; Vomhof P; Knecht S; Breitenstein C; Flöel A
    Physiol Behav; 2008 Mar; 93(4-5):1024-9. PubMed ID: 18294663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
    Lou JS; Kearns G; Benice T; Oken B; Sexton G; Nutt J
    Mov Disord; 2003 Oct; 18(10):1108-14. PubMed ID: 14534913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.
    Stocchi F; Rascol O; Kieburtz K; Poewe W; Jankovic J; Tolosa E; Barone P; Lang AE; Olanow CW
    Ann Neurol; 2010 Jul; 68(1):18-27. PubMed ID: 20582993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease.
    LeWitt PA; Huff FJ; Hauser RA; Chen D; Lissin D; Zomorodi K; Cundy KC
    Mov Disord; 2014 Jan; 29(1):75-82. PubMed ID: 24339234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-carbidopa and childhood retinal disease.
    Leguire LE; Jende DL; Nairus TM; Walson PD; Rogers GL; Bremer DL; McGregor ML
    J AAPOS; 1998 Apr; 2(2):79-85. PubMed ID: 10530967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate placebo effect in Parkinson's disease--is the subjective relief accompanied by objective improvement?
    Fregni F; Boggio PS; Bermpohl F; Maia F; Rigonatti SP; Barbosa ER; Pascual-Leone A
    Eur Neurol; 2006; 56(4):222-9. PubMed ID: 17057382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa.
    Metman LV; Hoff J; Mouradian MM; Chase TN
    Mov Disord; 1994 Jul; 9(4):463-5. PubMed ID: 7969216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
    Fung VS; Herawati L; Wan Y; ;
    Mov Disord; 2009 Jan; 24(1):25-31. PubMed ID: 18846551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.